These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3200559)

  • 1. Natural history of frequent recurrences of herpes simplex labialis.
    Davis LE; Redman JC; Skipper BJ; McLaren LC
    Oral Surg Oral Med Oral Pathol; 1988 Nov; 66(5):558-61. PubMed ID: 3200559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human herpes simplex labialis.
    Fatahzadeh M; Schwartz RA
    Clin Exp Dermatol; 2007 Nov; 32(6):625-30. PubMed ID: 17953630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
    Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
    J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer.
    Spruance SL; Green JA; Chiu G; Yeh TJ; Wenerstrom G; Overall JC
    Infect Immun; 1982 Jun; 36(3):907-10. PubMed ID: 6178690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of low-level light therapy using 1072 nm infrared light for the treatment of herpes simplex labialis.
    Dougal G; Lee SY
    Clin Exp Dermatol; 2013 Oct; 38(7):713-8. PubMed ID: 23731454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
    Strand A; Böttiger D; Gever LN; Wheeler W
    Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent herpes simplex labialis: selected therapeutic options.
    Raborn GW; Grace MG
    J Can Dent Assoc; 2003 Sep; 69(8):498-503. PubMed ID: 12954137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between host genetic variants and Herpes Simplex Labialis in the TwinsUK cohort.
    Santamaria P; Bowyer RCE; Nibali L
    Arch Oral Biol; 2023 Jan; 145():105587. PubMed ID: 36436332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Study on the Effectiveness of Three Products in the Treatment of Herpes Simplex Labialis.
    Boes H; Goulioumis V; Wechsler A; Zimmer S; Bizhang M
    Sci Rep; 2020 Apr; 10(1):6465. PubMed ID: 32296094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of recurrent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment.
    Spruance SL; Wenerstrom G
    Oral Surg Oral Med Oral Pathol; 1984 Dec; 58(6):667-71. PubMed ID: 6095159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient hosts.
    Aiuti F; Sirianni MC; Paganelli R; Stella A; Turbessi G; Fiorilli M
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):81-6. PubMed ID: 6341261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study.
    Gilbert SC
    J Drugs Dermatol; 2007 Apr; 6(4):400-5. PubMed ID: 17668537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
    N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient host: results after a 1-year follow-up.
    Aiuti F; Sirianni MC; Fiorilli M; Paganelli R; Stella A; Turbessi G
    Clin Immunol Immunopathol; 1984 Jan; 30(1):11-8. PubMed ID: 6321073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to replacement iron therapy in sideropenic individuals with recrudescent herpes labialis.
    Willis A; Hyland P; Lamey PJ
    Eur J Clin Microbiol Infect Dis; 2000 May; 19(5):355-7. PubMed ID: 10898136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of recurrent herpes labialis during an army hot weather exercise.
    Shulman JD; Carpenter WM; Lewis DL
    J Public Health Dent; 1992; 52(4):198-203. PubMed ID: 1512743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population.
    Young SK; Rowe NH; Buchanan RA
    Oral Surg Oral Med Oral Pathol; 1976 Apr; 41(4):498-507. PubMed ID: 1063349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.